media – Page 552 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

Accent raised $40 Million to Develop Epitranscriptomics Studies

Cambridge, Mass.-based Biotech startup Accent Therapeutics announced $40 million A series funding to develop cancer treatment based on epitranscriptomics, an RNA-modifying protein (RMPs) which have been connected to recent cancer studies.
- Source: Ddu
- 682
- May 21, 2018
biotech cancer Company Insight DNA
Aimovig a New Drug for Migraines Gets Approval from FDA

Aimovig, a ground-breaking drug to prevent Migraines was approved by the FDA last week. Aimovig will be the only player in the market to treat migraines. The new drug has to be taken once a month through an injection similar to an insulin shot or an EpiPen.
- Source: Ddu
- 658
- May 21, 2018
FDA migraine New Approvals
Breast Cancer Diagnosis Using a Pill

A research team at the University of Michigan were developing a pill which shows the presence of tumors when exposed to infrared light, and their concept worked well in mice.
- Source: Ddu
- 862
- May 21, 2018
breast cancer cancer Researches
Antibiotic contamination? – Clear away with Antibiotic resistant bacteria

Antibiotics play a major role in the medical field in order to eliminate the pathogens. Nowadays, the overutilization of antibiotics seems to be an upcoming disaster which not only leads to pollution via pharmaceutical wastes, but it had also increased the risk of antibiotic resistance.
- Source: Ddu
- 543
- May 21, 2018
antibiotic resistance Researches
Discovery of New Target to Treat Pulmonary Hypertension

Pulmonary hypertension is an acute lung disease which affects the right side of the heart, leading to increased blood pressure in the arteries of the lungs, since the artery walls become thickened. Research work is going on worldwide to discover the ultimate therapy for pulmonary hypertension.
- Source: Ddu
- 559
- May 21, 2018
hypertension Researches
Novel Blood Test to Predict TB

A research team led by Dr. Gerhard Walzl from Stellenbosch University in South Africa, has discovered a new blood test to predict tuberculosis development up to two years before its onset in high-risk patients. In the study, the expression level of four genes named “RISK4”, associated with inflammatory response, were measured.
- Source: Ddu
- 605
- May 21, 2018
Researches tuberculosis
Opt for Cancer Drug to forgo Tuberculosis

More than one-quarter of the world’s population were constantly getting affected with the one of the world’s oldest and deadliest disease named Tuberculosis (TB). In spite of 6-9 months antibiotic therapy, it’s very difficult to treat tuberculosis. That’s why researchers throughout the world were trying to find the faster ways of cure.
- Source: Ddu
- 601
- May 18, 2018
cancer Researches tuberculosis
Correct Color Blindness Using Contact Lens

Previous research on color blindness correction was conducted using gene therapy, while EnChroma developed sunglasses which could correct the issue. But they were bulky and expensive, and could not be used with regular corrective lenses.
- Source: Ddu
- 419
- May 18, 2018
color blind eyes Researches
Grand Challenge by Bill Gates against Universal Flu

In the pilot phase, individual grants would be provided which would range from $250,000 to $2 million over two years. An additional $10 million may be provided if project is promising in animal studies but that money won’t be the part of this funding round
- Source: Ddu
- 585
- May 18, 2018
flu influenza strains Researches
LifePlus announces glucose monitoring wearable

The company announced that the innovative product, whose technological details are not known yet, is undergoing clinical trials in five cities across the world. The patent-pending invention is based on open standards software and cloud-based analytics. The system gives users real-time notifications and cloud-based AI solutions.
- Source: Ddu
- 1,009
- May 18, 2018
Clinical Trials mHealth wearables

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.